Cost-effectiveness of colorectal cancer screening in the average risk population

被引：34
作者：
Moshe Leshno
Zamir Halpern
Nadir Arber
机构：
[1] Faculty of Management, Sackler Faculty of Medicine, Tel Aviv University
[2] Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv University
来源：
Health Care Management Science | 2003年 / 6卷 / 3期
关键词：
Carcinoma of colon and rectum; Cost-effectiveness analysis; Partially observed Markov decision process; Screening;
D O I：
10.1023/A:1024488007043
中图分类号：
学科分类号：
摘要：
Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.
引用
收藏
页码：165 / 174
页数：9
相关论文
共 54 条
  • [1] What Are the Key Statistics about Colorectal Cancer?, (2000)
  • [2] Landis S.H., Murray T., Bolden S., Cancer statistics, CA Cancer J. Clin., 48, pp. 6-29, (1998)
  • [3] Winawer S.J., Fletcher R.H., Miller L., Goodlee F., Colorectal cancer screening: Clinical guidelines and rationale, Gastroenterology, 113, pp. 594-642, (1997)
  • [4] Mandel J.S., Bond J.H., Church T.R., Snover B.C., Bradley G.M., Schuman L.M., Ederer F., Reducing morality from colorectal cancer by screening for fecal occult blood, N. Engl. J. Med., 328, (1993)
  • [5] Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J., Snover B.C., Schuman L.M., The effect of fecal occult-blood screening on the incidence of colorectal cancer, N. Engl. J. Med., 343, 22, pp. 1603-1607, (2000)
  • [6] Allison J., Tekewa I., Ransom L., Adrain A.A., The effect of fecal occult-blood screening on the incidence of colorectal cancer, N. Engl. J. Med., 343, pp. 155-159, (1996)
  • [7] Towler B., Irwig L., Glasziou P., Kewenter J., Weller B., Silagy C.A., Systematic review of the effects of screening for colorectal cancer using the fecal occult blood test, hemoccult, BMJ, 317, pp. 559-565, (1998)
  • [8] Eddy B.S., Screening for colorectal cancer, Ann. Int. Med., 113, pp. 373-384, (1990)
  • [9] Lieberman B.A., Cost-effectiveness model for colon cancer screening, Gastroenterology, 109, pp. 1781-1790, (1995)
  • [10] Wagner J.L., Tunis S., Brown M., Ching A., Almeida R., Cost-effectiveness of colorectal cancer screening in average-risk adults, Prevention and Early Detection of Colorectal Cancer, pp. 321-356, (1996)
123456